Bimatoprost ophthalmic solution is a prescription eye drop used primarily to lower eye pressure in people with glaucoma or ocular hypertension. It belongs to a class of medications called prostaglandin analogs, which work by helping fluid drain out of the eye more efficiently. The same active ingredient is also marketed under a different brand for a cosmetic purpose: growing longer, thicker eyelashes. You may know it by the brand names Lumigan (for glaucoma) or Latisse (for eyelash growth).
How It Lowers Eye Pressure
Your eye constantly produces a clear fluid called aqueous humor, which nourishes internal structures and maintains the eye’s shape. Normally this fluid drains out at the same rate it’s produced, keeping pressure stable. In glaucoma and ocular hypertension, drainage slows down, pressure builds, and the optic nerve can be gradually damaged.
Bimatoprost increases the outflow of this fluid through two drainage pathways in the eye: the trabecular meshwork (a sieve-like tissue near the front of the eye) and the uveoscleral route (a secondary pathway through deeper tissue layers). By opening up both routes, it typically lowers intraocular pressure by about 5 to 7 mmHg, which is clinically meaningful for most patients.
Available Concentrations
Bimatoprost comes in two strengths: 0.01% and 0.03%. The higher concentration lowers pressure slightly more, by roughly half a millimeter of mercury on average. That’s a small difference, and it comes with a tradeoff. In FDA review data, 62% of patients on the 0.03% solution reported ocular side effects compared to 48% on the 0.01% version. Three times as many people on the stronger formula discontinued treatment due to eye irritation. For many patients, the lower concentration offers a better balance of effectiveness and comfort.
Prostaglandin Analogs as First-Line Treatment
Four prostaglandin analogs are available in the United States for glaucoma: latanoprost, bimatoprost, travoprost, and tafluprost. In adults, these are commonly the first medications prescribed because they’re effective with once-daily dosing and have a relatively favorable side effect profile compared to older drug classes. In children, the approach differs. Beta-blockers and carbonic anhydrase inhibitors are typically tried first, with prostaglandin analogs reserved as second- or third-line options (though they may be used earlier in juvenile open-angle glaucoma).
How It Grows Eyelashes
Every eyelash goes through a growth cycle. The active growth phase, called the anagen phase, normally lasts about one to two months for eyelashes. Bimatoprost extends this phase, giving each lash more time to grow longer before it naturally falls out. Lashes also darken during this active growth phase, so the extended timeline means they become noticeably darker as well as longer. The cosmetic formulation (Latisse) is applied to the upper lash line with a sterile applicator rather than dropped into the eye. Results typically take several weeks to become visible, and lashes gradually return to their previous appearance if you stop using it.
Common Side Effects
The most frequent side effect is eye redness (hyperemia), which is more pronounced with the 0.03% concentration. Other common reactions include itching, a feeling of something in the eye, and dryness.
Bimatoprost can also cause cosmetic changes that catch people off guard. Eyelid skin darkening has been reported in up to about 26% of users in some studies. The skin around the eyes may develop a brownish discoloration that can be reversible after stopping treatment, though it doesn’t always fully resolve. More distinctively, the iris itself can permanently change color, particularly in people with mixed-color eyes (hazel or green-brown). This happens because bimatoprost stimulates melanin production in the iris. If you’re using the drops in only one eye, the color difference between your eyes can become noticeable, and this change may be irreversible.
Changes Around the Eye Socket
Long-term use of any prostaglandin analog, including bimatoprost, can cause a collection of changes known as prostaglandin-associated periorbitopathy. These changes develop gradually and may include deepening of the upper eyelid crease, a sunken appearance around the eyes from orbital fat loss, drooping of the upper eyelid, and flattening of the lower eyelid bags. In some cases, the eye itself can appear to sit slightly deeper in the socket. The underlying cause appears to involve the medication inhibiting fat cell development in the tissue surrounding the eye. These changes are more cosmetically concerning than medically dangerous, and they can partially reverse after stopping the medication, though recovery isn’t guaranteed.
Who Should Use It With Caution
Bimatoprost has no absolute contraindications listed in its FDA labeling, but several conditions call for careful consideration. People with active inflammation inside the eye, such as uveitis or iritis, risk worsening that inflammation. Patients who’ve had cataract surgery with a damaged lens capsule, or who have no natural lens at all, face a higher risk of macular edema, a condition where fluid accumulates in the central part of the retina and can affect vision. The medication also hasn’t been formally evaluated for angle-closure glaucoma, inflammatory glaucoma, or neovascular glaucoma, so it’s not typically prescribed for those types.
Because the multi-dose bottles contain a preservative called benzalkonium chloride, contact lens wearers need to remove their lenses before applying the drops and wait at least 15 minutes before reinserting them. The preservative can be absorbed by soft contact lenses and cause irritation over time. Keeping the bottle tip from touching your eye or any surface also matters, since contaminated bottles have been linked to bacterial infections of the cornea.
What to Expect When Using It
Bimatoprost for glaucoma is applied as one drop in the affected eye once daily, typically in the evening. Using it more frequently doesn’t improve results and may actually reduce its effectiveness. If you’re using other eye drops alongside it, spacing them at least five minutes apart prevents one drop from washing out the other. Store the bottle at room temperature and discard it according to the timeline your pharmacist provides, since preservative effectiveness diminishes over time.
Pressure reduction begins within a few hours of the first dose, but the full effect builds over several weeks of consistent use. Because glaucoma rarely causes noticeable symptoms until significant damage has occurred, the drops won’t make your vision feel different day to day. Regular pressure checks are the only way to confirm the medication is working. Stopping treatment without an alternative plan allows pressure to climb back up, putting the optic nerve at risk again.